P125: Ankylosing spondylitis can influence the outcome of inflammatory bowel diseaseECCO'22Year: 2022
Authors: Jun, Y.K.(1);Kim, A.H.(2);Park , J.(3);Choi, E.(4);Yoon, H.(3);Kang, H.W.(4);Lee, H.J.(5);Im, J.P.(5);Kim, J.S.(5);Seong-Joon , K.(5);
(1)Division of Gastroenterology & Hepatology- Department of Internal Medicine, Seoul national university hospital, Seoul, Korea- Republic Of;(2)Seoul National University, College of Medicine, Seoul, Korea- Republic Of;(3)Seoul National University Bundang Hospital, Department of Internal medicine- Division of Gastroenterology, Seongnam, Korea- Republic Of;(4)SMG-SNU Boramae medical Center, Department of Internal medicine- Division of Gastroenterology, Seoul, Korea- Republic Of;(5)Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;
P126: The predictive value of the modified Rutgeerts score at index endoscopy after primary ileocolic resection in patients with Crohn’s disease for the risk of re-resection and severe endoscopic inflammation after long-term follow-upECCO'22Year: 2022
Authors: Bak, M.(1);van Ruler, O.(2);Bodelier, A.(3);Dijkstra, G.(4);Romberg-Camps , M.(5);de Boer, N.(6);Hoentjen, F.(7);Stassen, L.(8);van der Meulen – de Jong , A.(9);West, R.(10);van der Woude, C.J.(1);de Vries, A.(1);
(1)Erasmus Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)IJsselland Hospital, Department of Surgery, Capelle aan den IJssel, The Netherlands;(3)Amphia Hospital, Department of Gastroenterology and Hepatology, Breda, The Netherlands;(4)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(5)Department of Gastroenterology- Geriatrics- Internal and Intensive Care Medicine Co-MIK, Zuyderland Medical Centre, Heerlen-Sittard-Geleen, The Netherlands;(6)Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(7)Radboud University Medical Center, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(8)Maastricht University Medical Center, Department of Surgery, Maastricht, The Netherlands;(9)Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, The Netherlands;(10)Franciscus Gasthuis & Vlietland, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;
P127: Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Bourgonje, A.R.(1);Alexdottir, M.(2);Loveikyte, R.(1);Pehrsson, M.(2);Bay-Jensen, A.C.(2);van Dullemen, H.M.(1);Visschedijk, M.C.(1);Festen, E.A.M.(1);Weersma, R.K.(1);Karsdal, M.A.(2);Faber, K.N.(1);Mortensen, J.H.(2);Dijkstra, G.(1);
(1)University of Groningen- University Medical Center Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands;(2)Nordic Bioscience, Immunoscience, Herlev, Denmark;
P128: Accuracy of the combination of transabdominal and transperineal ultrasound for the evaluation of Ulcerative Colitis activityECCO'22Year: 2022
Authors: Terracciano, F.(1);Bossa, F.(1);Marra, A.(1);Valvano, M.R.(1);Carparelli, S.(1);Ippolito, M.A.(1);Perri, F.(1);
(1)IRCCS Casa Sollievo della Sofferenza, Gastroenterology and Endoscopy Units, San Giovanni Rotondo, Italy;
P129: Hepcidin and ferritin index can help to differentiate between different types of anaemia: an exploratory studyECCO'22Year: 2022
Authors: BeversMD, N.(1);Adriaans, G.M.C.(2);Aliu, A.(1);Rezazadeh Ardabili, A.(2);Vreugdenhil, A.C.E.(3);de Almeida, R.(4);van Rheenen, P.F.(5);Pierik, M.J.(2);
(1)Zuyderland Medical Centre, pediatrics, Heerlen, The Netherlands;(2)School for Nutrition and Translational Research in Metabolism NUTRIM- Maastricht University Medical Center- Maastricht- t, Department of Internal Medicine- Division of Gastro-enterology and Hepatology- Maastricht University Medical Center, Maastricht, The Netherlands;(3)School for Nutrition and Translational Research in Metabolism NUTRIM- Maastricht University Medical Center- Maastricht- t, Department of Pediatrics- Division of Gastro-enterology and Hepatology- Maastricht University Medical Center, Maastricht, The Netherlands;(4)Maastricht University- School of Business and Economics, department of Quantitative Economics- department of Data analytics and Digitalisation, Maastricht, The Netherlands;(5)University Medical Centre Groningen- Beatrix Children's Hospital, Department of Paediatric Gastroenterology, Groningen, The Netherlands;
P130: Comparison of the clinical course of Ulcerative Colitis according to the presence or absence of clinical symptoms at the time of diagnosisECCO'22Year: 2022
Authors: Madarame, A.(1);Fukuzawa, M.(1);Uchida, K.(1);Nemoto, D.(1);Shinohara, H.(1);Yamanishi, F.(1);Matsumoto, S.(1);Suzuki, Y.(1);Muramatsu, T.(1);Kagawa, Y.(1);Matsumoto, T.(1);Morise, T.(1);Yamaguchi, H.(1);Sugimoto, A.(1);Kono, S.(1);Yamauchi, Y.(1);Naito, S.(1);Kawai, T.(2);Itoi, T.(1);
(1)Tokyo Medical Univercity Hospital, Gastroenterology and Hepatology, Tokyo, Japan;(2)Tokyo Medical University Hospital, Gastroenterological Endoscopy, Tokyo, Japan;
P131: Impact of Inflammatory Bowel Disease on patients’ caregivers: Results from a French cohortECCO'22Year: 2022
Authors: El HajjMD, W.(1);Buisson, A.(2);Olympie, A.(2);Ravel, M.H.(2);Devos, C.(2);Trang, C.(3);Nahon, S.(1);
(1)Groupe Hospitaliser Intercommunal Leraincy-Montfermeil, Ile de France, Montfermeil, France;(2)AFA Crohn-UC France Association François Aupetit, Ile de France, Paris, France;(3)CHU Nantes, Loire-Atlantique, Nantes, France;
P133: Point-of-care measurement of infliximab and adalimumab trough levels by the fluorescence resonance energy transfer (FRET) assayECCO'22Year: 2022
Authors: Cerna, K.(1);Kastylova, K.(1);Sebek, P.(2);Luxova, S.(3);Lukas, M.(1);
(1)ISCARE a.s., Clinical & Research Center fo Inflamamtory Bowel Disease, Prague, Czech Republic;(2)Tanigen s.r.o., TaniGen, Prague, Czech Republic;(3)GENNET s.r.o., Immunological Laboratory, Prague, Czech Republic;
P135: Usefulness of clinical and ultrasound indices to assess enthesis lesions in patients with inflammatory bowel diseases.ECCO'22Year: 2022
Authors: Gainullina, G.(1); Abdulganieva , D.(1);Kirillova, E.(1);Odintsova, A.(2);
(1)Kazan State Medical University, Hospital Therapy, Kazan, Russian Federation;(2)Republican Clinical Hospital, gastroenterology, Kazan, Russian Federation;
P136: Risk of polyps and colorectal cancer in patients with microscopic colitis: case-control study with long-term follow-upECCO'22Year: 2022
Authors: Fajardo, I.(1);Zabana, Y.(1,2);Salas, A.(3);Aceituno, M.(1,2);Ruiz, L.(1,2);Esteve, M.(1,2);Fernández-Bañares, F.(1,2);
(1)Hospital Universitari Mútua de Terrassa, Gastroenterology Department, Terrassa, Spain;(2)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, CIBERehd, Barcelona, Spain;(3)Hospital Universitari Mútua de Terrassa, Pathology Department, Terrassa, Spain;
P137: Lesions of Cytomegalovirus and Epstein Barr virus of the proximal gastrointestinal tract in patients with Inflammatory Bowel Disease after COVID-19.ECCO'22Year: 2022
Authors: Babayeva-Sadigova, G.(1,2);Makhmudov, U.(3);Quliyev, F.(4);Asadova, G.(1,4);Mirzazade, O.(1);Samadova, T.(1,4);Hasanova, A.(1);
(1)Azerbaijan State Advanced Training Institute for Doctors named after A.ALIYEV., department of Therapy, Baku, Azerbaijan;(2)Memorial Klinik, department of therapy and gastroenterology, Baku, Azerbaijan;(3)Modern Hospital, department of Gastroenterology and Endoscopy, Baku, Azerbaijan;(4)National Center of Oncology, department of Invasive Diagnosis and Therapy, Baku, Azerbaijan;IBD
P138: Psychometric validation and interpretation of a patient-reported outcomes instrument to assess bowel urgency among adults with moderate to severe Ulcerative ColitisECCO'22Year: 2022
Authors: Dubinsky, M.C.(1);Delbecque, L.(2);Lewis, J.(3);Hunter, T.(4);Shan, M.(5);
(1)Mount Sinai NY, Icahn School of Medicine, New York, United States;(2)Eli Lilly and Company, Global Patients Outcomes Real World Evidence, Brussels, Belgium;(3)University of Pennsylvania, Pereleman School of Medicine- Division of Gastroenterology and Hepatology, Philadelphia, United States;(4)Eli Lilly and Company, Global Patient Outcomes Real World Evidence, Indianapolis, United States;(5)Eli Lilly and Company, Real World Analytics, Indianapolis/IN, United States;
P139: Body composition and Crohn’s disease behavior: Is adiposity the main game changer?ECCO'22Year: 2022
Authors: Morão, B.(1);Velho, S.(2);Agostinho, L.(3);Torres, J.(1);Cravo, M.(4);
(1)Hospital Beatriz Ângelo, Gastroenterology, Lisbon, Portugal;(2)Hospital Beatriz Ângelo, Nutrition, Lisbon, Portugal;(3)Hospital Beatriz Ângelo, Radiology, Lisbon, Portugal;(4)Hospital da Luz, Gastroenterology, Lisboa, Portugal;
P140: Immunomodulators are protective against severe COVID 19: results from a large multicentre cohort of inflammatory bowel disease patientsECCO'22Year: 2022
Authors: Vuitton, L.(1);Bourrier, A.(2);Uzzan, M.(3);Nachury, M.(4);Amiot, A.(5);Roblin, X.(6);Allez, M.(7);Altwegg, R.(8);Vidon, M.(9);Bourreille, A.(10);Serrero, M.(11);Pelletier, A.L.(12);Filippi, J.(13);Gilletta, C.(14);Simon, M.(15);Laharie, D.(16);Nahon, S.(17);Duveau, N.(18);Biron, A.(19);Viennot, S.(20);Abitbol, V.(21);Elgharabawy, Y.(22);Peyrin-Biroulet, L.(23);
(1)Besançon University Hospital- Franche-Comté University- UMR 1098, Department of Gastroenterology, Besançon, France;(2)Saint Antoine University Hospital- Assistance Publique-Hôpitaux de Paris APHP, Gastroenterology, Paris, France;(3)Beaujon University Hospital- APHP, Gastroenterology, Clichy, France;(4)Lille University hospital, HepatoGastroenterology, Lille, France;(5)Mondor University Hospital- APHP, Hepatogastroenterology, Creteil, France;(6)St-Etienne university hospital, Hepatogastroenterology, Saint-Etienne, France;(7)Saint-Louis university hospital- APHP, Gastroenterology, Paris, France;(8)Montpellier university hospital, Hepatogastroenterology, Montpellier, France;(9)Centre Hospitalier Intercommunal de Créteil, HepatoGastroenterology, Créteil, France;(10)Nantes university Hospital, Hepatogastroenterology, Nantes, France;(11)Hôpital Nord de Marseille- APHM, Gastroenterology, Marseille, France;(12)Bichat hospital- APHP, Gastroenterology, Paris, France;(13)Nice University hospital, Gastroenterology, Nice, France;(14)Toulouse university hospital, Hepatogastroenterology, Toulouse, France;(15)IMM hospital, Gastroenterology, Paris, France;(16)Bordeaux university hospital, Hepatogastroenterology, Bordeaux, France;(17)Montfermeil hospital, Hepatogastroenterology, Montfermeil, France;(18)Roubaix hospital, Hepatogastroenterology, Roubaix, France;(19)Reims university hospital, Hepatogastroenterology, Reims, France;(20)Caen university hospital, Hepatogastroenterology, Caen, France;(21)Cochin university hospital- APHP, Gastroenterology, Paris, France;(22)GETAID, Methodology, Paris, France;(23)Nancy university hospital, Hepatogastroenterology, Nancy, France;GETAID COVID study group
P141: Factors Associated with Time to Clinical Remission in Pediatric Luminal Crohn’s disease: a Retrospective Cohort StudyECCO'22Year: 2022
Authors: Sassine, S.(1,2);Fadela Zekhnine, S.(1,2);Qaddouri, M.(1,2);Djani, L.(1,2);Cambron-Asselin, C.(1,2);Savoie-Robichaud, M.(1,2);Lin, Y.F.(1,2);Grzywacz, K.(1,2,3);Groleau, V.(1,2,3);Dirks, M.(1,3);Drouin, É.(1,2,3);Halac, U.(1,3);Marchand, V.(1,3);Girard, C.(1,2,3);Courbette, O.(1,2,3);Patey, N.(1,2,4);Dal Soglio, D.(1,2,4);Deslandres, C.(1,2,3);Jantchou, P.(1,2,3);
(1)Université de Montréal, Faculty of Medicine, Montréal, Canada;(2)CHU Sainte-Justine, Research Center, Montréal, Canada;(3)CHU Sainte-Justine, Gastroenterology, Montréal, Canada;(4)CHU Sainte-Justine, Pathology, Montréal, Canada;
P142: Inflammatory bowel diseases associated with primary immunodeficiency: a multicenter studyECCO'22Year: 2022
Authors: Malamut, G.(1);Simon, M.(2);Nachury, M.(3);Uzzan, M.(4);Serrero, M.(5);Fumery, M.(6);Trang-Poisson, C.(7);Zallot, C.(8);Abitbol, V.(1);Charbit-Henrion, F.(9);Gornet, J.M.(2);Picard, C.(10);Cerf-Bensussan, N.(11);Chaussade, S.(1);Sokol, H.(12);
(1)AP-HP. Centre- Université de Paris- Hôpital Cochin- Paris- France., Gastroenterology, Paris, France;(2)AP-HP. Nord-Université de Paris- Hôpital Saint Louis- Paris- France., Gastroenterology, Paris, France;(3)Hôpital Huriez CHRU de Lille, Gastroenterology, Lille, France;(4)AP-HP. Nord-Université de Paris- Hôpital Beaujon- Clichy- France., Gastroenterology, Clichy, France;(5)APHM Hôpital Nord, Gastroenterology, Marseille, France;(6)CHU Amiens-Picardie, Gastroenterology, Amiens, France;(7)CHU de Nantes, Gastroenterology, Nantes, France;(8)CHRU de Nancy, Gastroenterology, Gastroenterology, France;(9)AP-HP. Centre-Université de Paris- Hôpital Necker-Enfants Malades, Molecular Genetics, Paris, France;(10)AP-HP. Centre-Université de Paris- Hôpital Necker-Enfants Malades, Study Center of Primary Immunodeficiency, Paris, France;(11)Université de Paris- INSERM UMR 1163 and Imagine Institute, Laboratory of intestinal immunology, Paris, France;(12)AP-HP. Sorbonne Université- Hôpital Saint Antoine, Gastroenterology, Paris, France;GETAID (Groupe d'Étude Thérapeutique des Affections Inflammatoires du tube Digestif)
P143: Changes in the Clinical Phenotype and Behavior of Pediatric Luminal Crohn’s Disease at Diagnosis in the Last DecadeECCO'22Year: 2022
Authors: Sassine, S.(1,2);Savoie-Robichaud, M.(1,2);Lin, Y.F.(1,2);Djani, L.(1,2);Christine, C.A.(1,2);Qaddouri, M.(1,2);Fadela Zekhnine, S.(1,2);Grzywacz, K.(1,2,3);Groleau, V.(1,2,3);Dirks, M.(1,3);Drouin, É.(1,2,3);Halac, U.(1,3);Marchand, V.(1,3);Girard, C.(1,2,3);Courbette, O.(1,2,3);Patey, N.(1,2,4);Dal Soglio, D.(1,2,4);Deslandres, C.(1,2,3);Jantchou, P.(1,2,3);
(1)Université de Montréal, Faculty of Medicine, Montréal, Canada;(2)CHU Sainte-Justine, Research Center, Montréal, Canada;(3)CHU Sainte-Justine, Gastroenterology, Montréal, Canada;(4)CHU Sainte-Justine, Pathology, Montréal, Canada;
